Citigroup
FLNA

Citigroup’s Filana Therapeutics FLNA Stock Holding History

Citigroup’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-52,800
Closed -$1.55M – 5938
2024
Q3 		$1.55M Buy
+52,800
New +$1.22M ﹤0.01% 2891
2024
Q1 		– Sell
-55,000
Closed -$1.24M – 5827
2023
Q4 		$1.24M Buy
+55,000
New +$1.16M ﹤0.01% 2649

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Citigroup's FLNA Position: Q2 2026 in Review

Citigroup reduced its Filana Therapeutics (FLNA) stake by 5% in Q2 2026, selling an estimated $1 and leaving 19 shares worth $23. The position accounts for ﹤0.01% of the portfolio, ranked #5568.

Citigroup first reported a position in FLNA in Q2 2013 and has held it in 39 quarters since. The position peaked at $2.42M in Q3 2021. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Citigroup held 19 shares of Filana Therapeutics worth $23 as of Q2 2026.
  • Citigroup sold 1 Filana Therapeutics share in Q2 2026, an estimated $1.
  • Filana Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5568 holding.
  • Citigroup first reported a position in Filana Therapeutics in Q2 2013 and has held it in 39 quarters since.
  • Citigroup's Filana Therapeutics position peaked at $2.42M in Q3 2021.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.